BENEFITS AND HARMS OF DUTASTERIDE FOR PROSTATE CANCER IN THE RE-BIOPSY POPULATION FOR YEARS 1-2: A RE-ANALYSIS OF REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL

被引：0
|
作者：
Mir, Maria Carmen
Li, Jianbo
Kattan, Michael
Jones, J. S.
Stephenson, Andrew
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期
关键词：
D O I：
10.1016/j.juro.2014.02.2226
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP69-07
引用
收藏
页码：E817 / E817
页数：1
相关论文
共 50 条
  • [1] Re: Dutasteride Improves Outcomes of Benign Prostatic Hyperplasia When Evaluated for Prostate Cancer Risk Reduction: Secondary Analysis of the Reduction by Dutasteride of Prostate Cancer Events Trial
    Oelke, Matthias
    EUROPEAN UROLOGY, 2012, 61 (03) : 624 - 625
  • [2] EFFECT OF BASELINE PROSTATE CANCER RISK ON DUTASTERIDE EFFICACY IN THE REDUCE (REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS) STUDY
    Marberger, M.
    Pettaway, C.
    Tammela, T.
    Tindall, D. J.
    Teloken, C.
    Wilson, T. H.
    Castro, R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 300 - 301
  • [3] EFFICACY OF DUTASTERIDE IN MEN WITH LOW PROSTATE VOLUME IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDY
    Pettaway, Curtis A.
    Nickel, J. Curtis
    Marberger, Michael
    Wilson, Timothy H.
    Rittmaster, Roger S.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E855 - E855
  • [4] The influence of unscheduled biopsies on prostate cancer detection in the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial
    Andriole, G. L.
    Pettaway, C.
    Tindall, D. J.
    Rittmaster, R. S.
    Wilson, T. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Dutasteride Improves Outcomes of Benign Prostatic Hyperplasia When Evaluated for Prostate Cancer Risk Reduction: Secondary Analysis of the REduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial
    Roehrborn, Claus G.
    Nickel, J. Curtis
    Andriole, Gerald L.
    Gagnier, R. Paul
    Black, Libby
    Wilson, Timothy H.
    Rittmaster, Roger S.
    UROLOGY, 2011, 78 (03) : 641 - 646
  • [6] INCIDENCE OF BIOPSY-DETECTABLE PROSTATE CANCER IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL: BLINDED 2-YEAR RESULTS
    Andriole, Gerald L.
    P-ettaway, Curtis A.
    Teloken, Claudio
    Fowler, Ivy L.
    Somerville, Matt C.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 800 - 800
  • [7] REDUCTION IN SURGICAL AND NON-SURGICAL INTERVENTIONS FOR PROSTATE CANCER WITH DUTASTERIDE TREATMENT IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDY
    Rittmaster, R.
    Montorsi, F.
    Marberger, M.
    Roehrborn, C.
    Andriole, G.
    Somerville, M.
    Castro, R.
    Fueyo, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 275 - 275
  • [8] Effect of baseline characteristics on prostate cancer rates and risk reduction in the Reduction by Dutasteride of prostate Cancer Events REDUCE) trial
    Andriole, G.
    Brawley, O.
    Gomella, L.
    Marberger, M.
    Montorsi, F.
    Pettaway, C.
    Teloken, C.
    Tammela, T.
    Tindall, D.
    Rittmaster, R.
    EJC SUPPLEMENTS, 2009, 7 (02): : 407 - 408
  • [9] THE INFLUENCE OF UNSCHEDULED BIOPSIES ON PROSTATE CANCER DETECTION IN THE REDUCE (REDUCTION OF DUTASTERIDE IN CANCER EVENTS) TRIAL
    Marberger, M.
    Montorsi, F.
    Bostwick, D.
    Fowler, I. L.
    Wilson, T. H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 217 - 217
  • [10] Effect of inflammation on prostate cancer incidence and dutasteride efficacy in the Reduction by Dutasteride of Cancer Events (REDUCE) study.
    Brawley, O. W.
    Andriole, G. L.
    Teloken, C.
    Somerville, M. C.
    Gagnier, R. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345